This PDF file is for authors who want to publish under ASPET’s open access option It contains two forms in the following order:
Authorship Responsibility, Financial Disclosure, and Chemical Structure Statement Form. All authors of all manuscripts must complete this form.
Open Access License Agreement. All authors of the manuscript must complete this form if the manuscript is to be published under ASPET’s open access option. All authors must select the same Creative Commons license: either CC BY or CC BY-NC. Some funders require authors to use an open access option when it is available and require the CC BY license. Know your funder’s requirements prior to submission.
PLEASE NOTE: If you select the open access option after acceptance, you will incur additional fees. Know your funder’s requirements prior to submission. If you DO NOT want to publish under ASPET’s open access option, complete a Copyright Transfer Form instead at: http://pharmrev.aspetjournals.org/site/misc/PR_copyright_form.pdf The fields for manuscript number, manuscript title, corresponding author, telephone number, e-mail address, and address will automatically populate on both forms when entered on either one of them. For both forms, you may use additional pages for additional authors. Separate copies of each form may be circulated in order to collect the signatures of all of the authors on your manuscript. Questions about these forms should be sent to the ASPET Journals Department at
[email protected].
Manuscript Number:
American Society for Pharmacology and Experimental Therapeutics Authorship Responsibility, Financial Disclosure, and Chemical Structure Statement Form for Pharmacological Reviews Manuscript title:
Corresponding author: Telephone number:
Fax number:
Address:
E-mail Address:
Each author must read and sign below indicating their certification of the following statements: (1) authorship responsibility and (2) financial disclosure. If necessary, copy this document and distribute to coauthors for their signature. Please compile all forms and include them with the manuscript at the time of submission. Photocopy, facsimile, electronic, or other copies shall have the same effect for all purposes as an ink-signed original. 1. Authorship Responsibility (a) I certify that I have participated sufficiently in the conception and design of this work, the analysis of the data (where applicable), as well as the writing of this manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed this manuscript and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. All of the appropriate individuals are named as authors of this work. Neither this manuscript nor one with substantially similar content under my authorship has been published or will be submitted for publication elsewhere while under consideration by Pharmacological Reviews, except as described in an attachment. Furthermore, I attest that I shall produce the data on which the manuscript is based for examination by the editors or their assignees should they request it. (b) All authors must designate their specific contributions to the published work using the check boxes below each signature. This information is to be included as a footnote in the manuscript and will be published in the accepted paper. An individual author may be listed as having made more than one contribution, and more than one author may have contributed to the same aspect of the work.
Printed Author Name
Author Signature
Printed Author Name
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Author Signature
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Rev. Dec. 28, 2017
Printed Author Name
Author Signature
Printed Author Name
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Printed Author Name
Author Signature
Date
Printed Author Name
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Printed Author Name
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Author Signature
Author Signature
Author Signature
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Printed Author Name
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
Author Signature
Date
Participated in research design Conducted experiments Contributed new reagents or analytic tools Performed data analysis Wrote or contributed to the writing of the manuscript
2. Financial Disclosure I certify that any affiliations with or involvement (either competitive or amiable) in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript (e.g., employment, consultancies, stock ownership, honoraria, expert testimony, etc.) are noted below. All financial research or project support is identified in an acknowledgment in the manuscript. Statement of Financial Interest: (Check none or list. If more space is needed, submit a signed attachment.)
None 3. Chemical Structure
I certify that the chemical structure of all new compounds cited or discussed in the Work is presented or a citation to the published structure is provided, in accordance with the journal’s editorial policy.
Upload completed form with manuscript or Email to
[email protected] or Fax to +301-634-7158 or Mail to Pharmacological Reviews, ASPET, 9650 Rockville Pike, Suite E220 Bethesda, MD 20814-3995 USA Rev. Dec. 28, 2017
Manuscript Number:
American Society for Pharmacology and Experimental Therapeutics Open Access License Agreement for Pharmacological Reviews Complete this form in place of a copyright transfer form if you are publishing under the open access option.
Manuscript title:
Corresponding author: Telephone number:
E-mail:
Address: The copyedited and formatted version of accepted manuscripts published under this open access license agreement will be made freely accessible on the journal website immediately upon publication. The open access fee is charged in addition to all other applicable author charges (manuscript submission fee, page charges, and optional reprints). The open access fee must be paid via the Copyright Clearance Center RightsLink© system prior to publication. The corresponding author will receive a form with the article’s page proofs for page charges and optional reprints. Each author must read and sign below. If necessary, copy this document and distribute to coauthors for their signature. Please compile all forms and upload them with the manuscript at the time of submission. In the case of a “work made for hire,” the agreement must also be signed by an authorized agent of the Employer. This agreement shall be effective when signed below or in counterpart, and photocopy, facsimile, electronic, or other copies shall have the same effect for all purposes as an ink-signed original. Authors who select the open access publishing option agree to license their work under either the [CHECK ONE]:
Creative Commons Attribution 4.0 International (CC BY) - $3,000.00 plus applicable author charges (https://creativecommons.org/licenses/by/4.0/; this license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited) OR Creative Commons Attribution-Noncommercial 4.0 International (CC BY-NC) - $2,000.00 plus applicable author charges (https://creativecommons.org/ licenses/by-nc/4.0/; this license permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited)
In consideration of The American Society for Pharmacology and Experimental Therapeutics (“the Publisher”) reviewing, editing, and publishing this submission (“the Work”) in Pharmacological Reviews when and if the Work is accepted for publication, the undersigned author(s) (“the Authors”) or, where the Work is a “work made for hire” for an employer (“the Employer”), the Employer agrees to the following terms: A.
To pay the applicable open access fee and other author fees such as the manuscript submission fee, page charges, and—if incurred—reprint charges. B. The Author(s) or the Employer retains ownership of all rights under copyright in all versions of the Work, and all rights not expressly granted in this agreement. C. To facilitate dissemination of the Work, the Author(s)/Employer grants to the Publisher during the full term of the Author’s(s’)/Employer’s copyright and any extensions or renewals, a nonexclusive license of all rights of copyright in and to the Work, and all rights therein, including but not limited to the right to publish, republish, transmit, sell, distribute, and otherwise use the Work in whole or in part in electronic and print editions of the journal and in derivative works throughout the world, in all languages and in all media of expression now known or later developed, and to license or permit others to do so. D. All Authors listed in the Work agree to its publication and to this agreement. E. The Author(s) or, if applicable, the Employer, warrants that his/her contribution is original; that he/she has full power to make this grant; and the Work does not infringe the copyright or any other proprietary right (including without limitation the copyright, patent, or trademark rights) of any party. F. The Work contains no libelous or otherwise unlawful matter and statements.
Rev. Dec. 28, 2017
G. Either that the Work has not been previously published or, if portions have been previously published, that permission has been obtained for publication for all uses as set forth in the Creative Commons license selected and the Author(s) will submit a copy of the permission release and language for credit lines with his/her manuscript. H. Neither the Author(s) nor the Employer will receive any royalty or other monetary compensation from the Publisher for publishing the Work. I. In accordance with the Creative Commons License selected above, users are free (i) to copy, distribute, and transmit the work, (ii) to make derivative works, and (iii) to use this Work for other purposes (for only noncommercial purposes if the CC BY-NC license is selected). J. The Publisher will publish and distribute the Work with the appropriate copyright notice in the name of the Author(s)/Employer where applicable. K. Attribution: Original authorship must be fully attributed, and Pharmacological Reviews must be attributed as the original source of publication with proper citation details. Use the section below if your manuscript is a work made for hire or your employer for any reason requires personnel in addition to, or in place of the authors, to sign this license agreement.
Printed Author Name
Author Signature
Date
Printed Author Name
Author Signature
Employer
Date
Title
Printed Author Name
Author Signature
Signature
Date
Agency
Printed Author Name Author Signature
Date
Title Date
Signature
Date
Printed Author Name
Author Signature
Upload completed form with manuscript or Email to
[email protected] or Fax to +301-634-7158 or Mail to Pharmacological Reviews ASPET 9650 Rockville Pike, Suite E220 Bethesda, MD 20814-3995 USA
Date
Printed Author Name
Author Signature
Date
Printed Author Name
Author Signature
Date
Printed Author Name
Author Signature
Date
Use an additional sheet for additional authors. Signature, date, and printed name are required for each author. Rev. Dec. 28, 2017
